| Literature DB >> 22645519 |
Cathy E Elks1, Marcel den Hoed, Jing Hua Zhao, Stephen J Sharp, Nicholas J Wareham, Ruth J F Loos, Ken K Ong.
Abstract
Evidence for a major role of genetic factors in the determination of body mass index (BMI) comes from studies of related individuals. Despite consistent evidence for a heritable component of BMI, estimates of BMI heritability vary widely between studies and the reasons for this remain unclear. While some variation is natural due to differences between populations and settings, study design factors may also explain some of the heterogeneity. We performed a systematic review that identified 88 independent estimates of BMI heritability from twin studies (total 140,525 twins) and 27 estimates from family studies (42,968 family members). BMI heritability estimates from twin studies ranged from 0.47 to 0.90 (5th/50th/95th centiles: 0.58/0.75/0.87) and were generally higher than those from family studies (range: 0.24-0.81; 5th/50th/95th centiles: 0.25/0.46/0.68). Meta-regression of the results from twin studies showed that BMI heritability estimates were 0.07 (P = 0.001) higher in children than in adults; estimates increased with mean age among childhood studies (+0.012/year, P = 0.002), but decreased with mean age in adult studies (-0.002/year, P = 0.002). Heritability estimates derived from AE twin models (which assume no contribution of shared environment) were 0.12 higher than those from ACE models (P < 0.001), whilst lower estimates were associated with self reported versus DNA-based determination of zygosity (-0.04, P = 0.02), and with self reported versus measured BMI (-0.05, P = 0.03). Although the observed differences in heritability according to aspects of study design are relatively small, together, the above factors explained 47% of the heterogeneity in estimates of BMI heritability from twin studies. In summary, while some variation in BMI heritability is expected due to population-level differences, study design factors explained nearly half the heterogeneity reported in twin studies. The genetic contribution to BMI appears to vary with age and may have a greater influence during childhood than adult life.Entities:
Keywords: body mass index; family study; heritability; twin study
Year: 2012 PMID: 22645519 PMCID: PMC3355836 DOI: 10.3389/fendo.2012.00029
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure A1Modeling heritability in twin studies. This diagram shows how twin studies can model variance components, based on the path diagram proposed by Neale and Cardon (1992). The lines adjoining variance components indicate the degree of correlation (r), shown for both monozygotic (MZ) and dizygotic (DZ) twins. Additive genetic variance (A) is 100% correlated for MZ twin pairs and 50% correlated for DZ twin pairs. Common environment is shared (C) 100% by both types of twin. E represents a unique environmental component, and hence there is no correlation. Statistical modeling allows phenotypic variance to be quantitatively decomposed into A, C, and E subcomponents (the ACE model). The estimate of A gives a measure of the heritability of the trait. In a more parsimonious AE model, the C component would be missing from this diagram.
Figure A2Flow chart of identification of relevant literature.
Details of the 31 papers reporting BMI heritability from twin studies.
| Reference | Location | Source | Mean age (range) | Zygosity determinant | BMI measure | Best fitting model | Heritability estimate | ||
|---|---|---|---|---|---|---|---|---|---|
| Sex | 95% CI | ||||||||
| Watson et al. ( | USA | University of Washington Twin Registry | 1,224 | 36.9 (>18) | Questionnaire | Self report | ACE | 0.76 (m/f) | 0.54, 0.80 |
| Lajunen et al. ( | Finland | FinnTwin12 Study | 4,650 | 11.4 (11–12) | Questionnaire | Self report | ACE | 0.69 (m) 0.58 (f) | 0.56, 0.84 0.44, 0.74 |
| Hur et al. ( | Australia (A), Finland (F), Netherlands (N), USA (U) | Study of melanoma risk factors, FinnTwin12, Netherlands Twin Registry, Minnesota Twin Family Study | 7,470 | 14.1 (13–15) | Questionnaire; DNA-based in uncertain cases/same sex pairs | Clinical (A, U, C, J); Self report (F, N, J, K, T) | ACE | 0.81 (m) 0.82 (f) | 0.70, 0.90 0.73, 0.90 |
| China (C), Japan (J), South Korea (K), Taiwan (T) | Guangzhou Twin Registry, Tokyo Twin Cohort, South Korean Twin Registry, Taiwan Adolescent Twin/Sibling Family Study | 3,168 | 14.0 (13–15) | DNA (C, T), Questionnaire (J, K; uncertain cases excluded) | Clinical (C, J); Self report (J, K, T) | ACE | 0.74 (m) 0.85 (f) | 0.56, 0.93 0.75, 0.94 | |
| Liu et al. ( | Taiwan | Twin/Sibling Study of Insulin Resistance | 396 | 14.1 (12–18) | DNA-based | Clinical | AE | 0.89 (m/f) | 0.85, 0.92 |
| Wardle et al. ( | UK | Twin’s Early Development Study | 10,184 | 9.9 (8–11) | Questionnaire; DNA-based in uncertain cases | Self report | ACE | 0.80 (m) 0.72 (f) | 0.72, 0.84 0.63, 0.81 |
| Cornes et al. ( | Australia | Schools in Brisbane area, media appeals | 1,812 | 12 | Questionnaire; DNA confirmation in DZ/same sex pairs | Clinical | ADE | 0.77 (m) 0.76 (f) | 0.52, 0.91 0.48, 0.90 |
| Hur ( | South Korea | South Korean Twin Registry (SKTR) | 1,776 | 15.6 (13–19) | Questionnaire | Self report | AE | 0.82 (m) 0.87 (f) | 0.72, 0.95 0.77, 0.99 |
| Ordonana et al. ( | Netherlands, Spain | Netherlands and Murcia Twin Registers | 1,324 | (41–67) | DNA-based | Self report | AE | 0.77 (m/f) | 0.72, 0.81 |
| Silventoinen et al. ( | Netherlands | Netherlands Twin Register | 15,510 | 3 | Questionnaire | Self report | ACE | 0.70 (m) 0.68 (f) | 0.62, 0.77 0.60, 0.76 |
| Silventoinen et al. ( | Sweden | Swedish Young Male Twins Study | 678 | 18 | Questionnaire; DNA-based in uncertain cases | Clinical | AE | 0.84 (m) | 0.81, 0.88 |
| Souren et al. ( | Belgium | East Flanders Prospective Twin Survey | 756 | 25.3 (18–34) | DNA-based | Clinical | AE | 0.85 (m) 0.75 (f) | 0.79, 0.89 0.67, 0.81 |
| Nelson et al. ( | USA | Carolina African American Twin Study of Aging | 434 | 47.0 (22–88) | Questionnaire | Clinical | AE | 0.74 (m) 0.74 (f) | 0.61, 0.88 0.63, 0.84 |
| Schousboe et al. ( | Denmark | GEMINAKAR Study | 1,248 | 37.8 (18–67) | DNA-based | Clinical | ACE | 0.63 (m) 0.58 (f) | 0.36, 0.90 0.34, 0.82 |
| Schousboe et al. ( | Australia | Australian Twin Register | 5,000 2,832 | 20–29 30–39 | Questions; blood groups; DNA-based | Self report | AE | 0.69 (m) 0.74 (f) 0.77 (m) 0.75 (f) | 0.75, 0.64 0.71, 0.76 0.72, 0.82 0.72, 0.78 |
| Denmark | Danish Twin Registry | 11,096 8,094 | 20–29 30–39 | Questionnaire | Self report | AE | 0.78 (m) 0.73 (f) 0.63 (m) 0.74 (f) | 0.75, 0.80 0.71, 0.76 0.58, 0.67 0.71, 0.78 | |
| Finland | Finnish Twin Cohort Study and FinnTwin16 | 3,976 11,564 | 20–29 30–39 | Questionnaire | Self report | AE | 0.74 (m) 0.80 (f) 0.73 (m) 0.66 (f) | 0.69, 0.80 0.77, 0.84 0.71, 0.76 0.63, 0.70 | |
| Italy | National Twin Registry | 820 | 20–29 | Questionnaire | Self report | AE | 0.71 (m) 0.81 (f) | 0.60, 0.82 0.76, 0.87 | |
| Netherlands | Netherlands Twin Registry | 3,696 582 | 20–29 30–39 | Questionnaire; DNA in subset of 535 twins | Self report | AE | 0.68 (m) 0.81 (f) 0.79 (m) 0.67 (f) | 0.62, 0.74 0.78, 0.84 0.66, 0.92 0.58, 0.67 | |
| Norway | Norwegian Institute of Public Health Twin Study | 6,782 1,148 | 20–29 30–39 | Questionnaire | Self report | ACE AE AE | 0.53 (m) 0.73 (f) 0.78 (m) 0.83 (f) | 0.38, 0.67 0.70, 0.76 0.70, 0.87 0.78, 0.88 | |
| Sweden | Swedish Twin Registry | 9,518 7,300 | 20–29 30–39 | Questionnaire | Self report | AE | 0.75 (m) 0.74 (f) 0.72 (m) 0.75 (f) | 0.73, 0.78 0.72, 0.77 0.69, 0.75 0.72, 0.78 | |
| UK | St Thomas’ UK Adult Twin Registry | 328 622 | 20–29 30–39 | Questionnaire; DNA in 50% | Self report | AE | 0.73 (f) 0.81 (f) | 0.64, 0.81 0.77, 0.86 | |
| Baird et al. ( | UK | Birmingham birth registry | 396 | 43.7 | Questionnaire | Clinical | AE | 0.77 (m/f) | 0.67, 0.85 |
| Poulsen et al. ( | Denmark | Danish Twin Register | 606 | 67.0 (55–74) | Questionnaire | Clinical | Corr | 0.58 (m) 0.90 (f) | 0.40, 0.76 0.59, 1.00 |
| Faith et al. ( | USA | Ohio twin fair | 132 | 11.0 (3–17) | Questionnaire; blood testing | Clinical | AE | 0.88 (m/f) | 0.82, 0.95 |
| Knoblauch et al. ( | Germany | Studies of cardiovascular phenotypes and blood pressure regulation | 444 | 34.0 | DNA-based | Clinical | AE | 0.86 (m/f) | 0.59, 1.00 |
| Narkiewicz et al. ( | Poland | Twins reared together and apart | 66 | 20.9 (SD = 5) | DNA-based | Clinical | ACE | 0.76 (f) | 0.28, 1.00 |
| Pietilainen et al. ( | Finland | FinnTwin16 | 4,884 | 16.2 | Questionnaire; photographs; DNA-based | Self report | AE | 0.82 (m) 0.88 (f) | 0.79, 0.86 0.86, 0.90 |
| Vinck et al. ( | Belgium | East Flanders Prospective Twin Survey, town registers | 182 | 22.0 (17–38) | Questionnaire | Clinical | AE | 0.85 (m) | 0.64, 1.00 |
| Austin et al. ( | USA | Kaiser Permanente Women’s Twin Study | 630 | 18–85 | DNA-based | Clinical | AE | 0.83 (f) | 0.79, 0.87 |
| Herskind et al. ( | Denmark | Danish Twin Register | 1,602 864 | 46–59 60–76 | Questionnaire; unknown cases excluded | Self report | AE | 0.47 (m) 0.75 (f) 0.51 (m) 0.78 (f) | 0.37, 0.57 0.70, 0.80 0.37, 0.64 0.71, 0.84 |
| Carmichael and McGue ( | USA | Minnesota Twin Registry and Twin Study of Adult Development | 1,475 | 31.8 (18–38) | Questionnaire | Self report | AE | 0.82 (m/f) | 0.78, 0.86 |
| Forbes et al. ( | USA | Newspaper advertisement | 174 | 7–68 | DNA-based | Clinical | Corr | 0.75 (m/f) | 0.57, 0.93 |
| Harris et al. ( | Norway | New Norwegian Twin Panel | 4,508 | 18–25 | Questionnaire | Self report | AE | 0.72 (m) 0.83 (f) | 0.67, 0.77 0.80, 0.85 |
| Korkeila et al. ( | Finland | Finnish Twin Cohort | 4,988 4,606 2,858 2,038 | 18–24 25–34 35–44 45–54 | Questionnaire; unknown cases excluded | Self report | AE | 0.74 (m) 0.68 (f) 0.73 (m) 0.73 (f) 0.71 (m) 0.73 (f) 0.67 (m) 0.58 (f) | 0.70, 0.78 0.64, 0.72 0.69, 0.77 0.68, 0.77 0.65, 0.76 0.69, 0.79 0.59, 0.75 0.49, 0.67 |
| Neale and Cardon ( | Australia | Australian NH and MRC study | 3,522 3,616 | 18–30 >31 | Questionnaire | Self report | ADE | 0.76 (m) 0.79 (f) 0.75 (m) 0.70 (f) | 0.71, 0.81 0.76, 0.82 0.71, 0.80 0.66, 0.74 |
| Hewitt et al. ( | UK | Birmingham Family Study Register | 160 | 19.3 (16–24) | Questionnaire | Clinical | AE | 0.84 (m) | 0.74, 0.93 |
| Stunkard et al. ( | Sweden | Swedish Adoption/Twin Study of Aging (SATSA) | 1,346 | 58.6 | Questionnaire | Self report; clinical subset | ADE | 0.70T (m) 0.50T (f) 0.66A (m) 0.59A (f) | 0.53, 0.88 0.24, 0.76 0.55, 0.77 0.48, 0.70 |
| Stunkard et al. ( | USA | National Academy of Sciences-National Research Council Twin Registry Panel | 8,142 | 20.0 (15–28) | Questions; blood groups; DNA-based | Clinical | Corr | 0.77 (m) | 0.69, 0.84 |
.
.
.
.
Figure 1Histogram showing the wide distribution of reported estimates of BMI heritability from twin studies (white bars) and family studies (gray bars).
Figure 2Meta-analysis of BMI heritability estimates in twin studies. The forest plot shows the results of a random effects meta-analysis of 88 independent BMI heritability estimates from 31 papers.
Results of meta-regression analyses to identify study-level demographic factors associated with reported BMI heritability estimates in twin studies.
| Covariate | Co-efficient (SE) | Heritability estimate for reference group | 95% CI | |
|---|---|---|---|---|
| Sex (male = 0, female = 1) | 0.019 (0.02) | 0.267 | 0.73 | 0.71, 0.76 |
| Age category (childhood = 0, adulthood = 1) | −0.07 (0.02) | 0.80 | 0.77, 0.84 | |
| Age in childhood | 0.012 (0.003) | 0.77 | 0.74, 0.81 | |
| Age in adulthood | −0.002 (0.001) | 0.77 | 0.74, 0.79 | |
| Setting (Europe/USA = 0, East Asian = 1) | 0.105 (0.04) | 0.74 | 0.73, 0.76 | |
| Publication year (per +1 year from 1986 to 2010) | 0.003 (0.001) | 0.055 | 0.71 | 0.67, 0.75 |
Three estimates excluded from meta-regression for age as age range >20 years and no mean age reported.
Bold represents .
.
.
Figure 3Predicted BMI heritability by age. The dotted line represents predicted BMI heritability by age, modeled using piecewise linear splines with a knot point at age 18 to separate childhood and adulthood. The figure shows that the relative contribution of genetic factors to variation in BMI increases over childhood before declining during adult life. Each circle represents an individual estimate of BMI heritability, and the size of the circle is proportional to the inverse of the SE of the heritability estimate. Age is based on the mean age of the study sample, or the mid-point of the age range where this was not reported.
Results of meta-regression analyses to identify study-level methodological factors associated with reported BMI heritability estimates in twin studies.
| Covariate(s) Added | Co-efficient (SE) | Heritability estimate for reference group | 95% CI | Percentage of between study variance explained | |
|---|---|---|---|---|---|
| Sample size (per participant) | −0.000 (0.00) | 0.202 | 0.82 | 0.77, 0.86 | 4.13 |
| Twin model used (ACE = 0, AE = 1) | 0.118 (0.03) | 0.74 | 0.70, 0.79 | 21.89 | |
| Zygosity determinant (DNA-based/biological = 0, Questionnaire-based = 1) | −0.04 (0.02) | 0.81 | 0.78, 0.85 | 8.65 | |
| BMI measurement method (clinical = 0, self report = 1) | −0.048 (0.02) | 0.83 | 0.78, 0.88 | 9.91 |
All meta-regression analyses adjusted for age category.
Bold represents .
* τ.
Details of the 25 papers reporting BMI heritability from family studies.
| References | Location | Study | Mean age (range) | BMI heritability | 95% CI | |
|---|---|---|---|---|---|---|
| Friedlander et al. ( | Israel | Kibbutzim Family Study, Israel | 476 | NS | 0.64 | 0.42, 0.86 |
| Zabaneh et al. ( | UK | Asian Indian families living in UK | 1,634 | 39.4 (25–50) | 0.30 | 0.24, 0.36 |
| de Oliveira et al. ( | Brazil | Baependi Heart Study | 1,666 | 44.0 | 0.51 | 0.42, 0.60 |
| Bogaert et al. ( | Belgium | Semi-rural communities in Ghent | 674 | 25–45 | 0.81 | 0.61, 1.00 |
| Patel et al. ( | USA | Cleveland Family Study | 1,802 | 35.3 | 0.55 | 0.47, 0.63 |
| Bastarrachea et al. ( | Mexico | Genetics of Metabolic Diseases Family Study (GEMM) | 375 | 40.3 (12–90) | 0.36 | 0.16, 0.56 |
| Bayoumi et al. ( | Saudi Arabia | Oman Family Study | 1,198 | 33.8 (16–80) | 0.68 | 0.58, 0.78 |
| Butte et al. ( | USA | Viva La Familia Study (Hispanic Population, overweight proband) | 1,030 | 4–19 | 0.39 | 0.23, 0.55 |
| Deng et al. ( | China | Local Shanghai population (Chinese Han ethnic group) | 1,031 | (20–45, offspring) | 0.49 | 0.35, 0.63 |
| Li et al. ( | USA | Mexican-American Coronary Artery Disease (MACAD) project | 478 | 34.4 | 0.59 | 0.35, 0.83 |
| Sale et al. ( | USA | African American families with T2D affected members | 580 | 58.0 > 18 | 0.64 | 0.44, 0.84 |
| Henkin et al. ( | USA | Insulin Resistance and Atherosclerosis Study (IRAS) | 1,032 | 43.1 | 0.54 | 0.38, 0.70 |
| Wu et al. ( | Taiwan | Follow up of Mei-Jo Health Screening Programme | 1,724 | 9–81 | 0.39 | 0.31, 0.47 |
| Arya et al. ( | India | Nutrition and Growth of Certain Population Groups of Visakhapatnam (NAG Project) | 1,903 | 21.5 (6–72) | 0.25 | 0.15, 0.35 |
| Coady et al. ( | USA | Framingham Heart Study Families | 1,051 | 35.3* (35–55) | 0.37 | 0.21, 0.53 |
| Hunt et al. ( | Canada | Canada Fitness Survey | 1,315 | 29.6 (7–69) | 0.39 | 0.27, 0.51 |
| Jee et al. ( | Korea | Korea Medical Insurance Corporation (KMIC) family study | 7,589 | 59.8 (40–85) | 0.26 | 0.24, 0.28 |
| Abney et al. ( | USA | Hutterites of South Dakota | 666 | >5 | 0.54 | 0.40, 0.68 |
| Luke et al. ( | Nigeria | International Collaborative Study on Hypertension in Blacks | 1,815 | 38.8 (0–100) | 0.49 | 0.39, 0.59 |
| Jamaica | 614 | 39.5 (0–100) | 0.53 | 0.35, 0.71 | ||
| USA | 2,097 | 37.5 (0–100) | 0.57 | 0.47, 0.67 | ||
| Treuth et al. ( | USA | Houston area | 303 | 28.7 (8–9, offspring) | 0.35 | 0.02, 0.68 |
| Bijkerk et al. ( | Netherlands | Rotterdam Study | 1,583 | 63.1 (55–70) | 0.53 | 0.34, 0.75 |
| Vogler et al. ( | Denmark | Danish Adoption Register | 2,476 | 42.0 | 0.34 | 0.28, 0.40 |
| Moll et al. ( | USA | The Muscatine Ponderosity Study | 1,580 | 29.4 (4–67) | 0.58 | 0.46, 0.70 |
| Hunt et al. ( | USA | Utah pedigrees | 1,102 | 35.5 | 0.24 | 0.14, 0.34 |
| Longini et al. ( | USA | Tecumseh population | 5,174 | 6–74 | 0.35 | 0.23, 0.47 |
.
Figure 4Meta-analysis of BMI heritability estimates in family studies. The forest plot shows the results of a random effects meta-analysis of 27 independent BMI heritability estimates from 25 papers.
Results of meta-regression analyses to identify study-level demographic or methodological factors associated with reported BMI heritability estimates in family studies.
| Covariate(s) added | Co-efficient (SE) | Heritability estimate for reference group | 95% CI | |
|---|---|---|---|---|
| Sample size (per participant) | −0.000 (0.00) | 0.132 | 0.60 | 0.42, 0.78 |
| Age | 0.005 (0.005) | 0.358 | 0.28 | 0.00,0.71 |
| Setting (Europe/USA = 0, East Asian = 1) | −0.048 (0.11) | 0.68 | 0.48 | 0.39, 0.58 |
| Publication year (per +1 year from 1984 to 2010) | 0.009 (0.006) | 0.184 | 0.30 | 0.03, 0.57 |
*Assessed as mean age where possible (.
Four estimates excluded from meta-regression for age as mean age or full age range of parents and children were not reported.